Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by Biotricity, Inc. Biotricity Reports Financial Results for Fiscal 2022 Fourth Quarter and Full Year July 14, 2022 From Biotricity, Inc. Via AccessWire Exposures COVID-19 Tickers BTCY Biotricity to Join Russell Microcap(R) Index June 23, 2022 From Biotricity, Inc. Via AccessWire Tickers BTCY Biotricity to Present at the 2022 H.C. Wainwright Global Investment Conference on Tuesday May 24th May 23, 2022 From Biotricity, Inc. Via AccessWire Tickers BTCY Biotricity Issues Shareholder Update May 05, 2022 From Biotricity, Inc. Via AccessWire Exposures COVID-19 Tickers BTCY Biotricity to Launch Commercial Sales of Its Disruptive Cardiac Monitoring Device, Biotres in April 2022 March 22, 2022 From Biotricity, Inc. Via AccessWire Exposures Product Safety Tickers BTCY Biotricity Named to Fast Company's Annual List of the World's 50 Most Innovative Companies for 2022 March 08, 2022 From Biotricity, Inc. Via AccessWire Tickers BTCY Biotricity, Inc. to Attend 34th Annual Roth Conference March 13th-15th March 04, 2022 From Biotricity, Inc. Via AccessWire Tickers BTCY Biotricity Now Taking Pre-Orders for its Biotres Wireless Wearable Cardiac Monitoring Device February 23, 2022 From Biotricity, Inc. Via AccessWire Exposures Product Safety Tickers BTCY Biotricity Releases Fiscal 2022 Third Quarter Financial Results February 14, 2022 From Biotricity, Inc. Via AccessWire Tickers BTCY Biotricity to Report Third Quarter Fiscal 2022 Financial Results on February 14, 2022 February 08, 2022 From Biotricity, Inc. Via AccessWire Exposures Product Safety Tickers BTCY Biotricity Receives FDA 510(k) Clearance for its Biotres Cardiac Monitoring Device January 24, 2022 From Biotricity, Inc. Via AccessWire Exposures Product Safety Tickers BTCY Biotricity Expands Distribution of New Bioheart Device on Amazon.com December 28, 2021 From Biotricity, Inc. Via AccessWire Tickers BTCY Biotricity Completes $12 Million Non-Dilutive Debt Financing December 27, 2021 From Biotricity, Inc. Via AccessWire Tickers BTCY Biotricity, a Leader in Remote Cardiac Health Monitoring Solutions, Issues Company Roadmap in 2021 Shareholder Letter December 07, 2021 From Biotricity, Inc. Via AccessWire Topics Regulatory Compliance Exposures Legal Regulatory Tickers BTCY Biotricity Delivers Bioheart, A Groundbreaking Consumer Heart Monitor November 10, 2021 From Biotricity, Inc. Via Business Wire Tickers BTCY Biotricity Releases Fiscal 2022 Second Quarter Financial Results November 04, 2021 From Biotricity, Inc. Via AccessWire Topics Regulatory Compliance Exposures Legal Product Safety Regulatory Tickers BTCY Biotricity to Report Second Quarter Fiscal 2022 Financial Results on November 4, 2021 November 02, 2021 From Biotricity, Inc. Via AccessWire Topics Regulatory Compliance Exposures Legal Regulatory Tickers BTCY Biotricity to Discuss its Breakthrough Patient Monitoring Solutions at Virtual LD Micro Main Event XIV on Oct. 13th October 12, 2021 From Biotricity, Inc. Via AccessWire Topics Regulatory Compliance Exposures Legal Regulatory Tickers BTCY Biotricity Launches Biocare Cardiac Application for Samsung's Galaxy Watch4 Series October 07, 2021 From Biotricity, Inc. Via AccessWire Topics Regulatory Compliance Exposures Legal Product Safety Regulatory Tickers BTCY Remote Medical Diagnostic Company, Biotricity, to Ring the Nasdaq Stock Market Opening Bell on Thursday, October 7th October 06, 2021 From Biotricity, Inc. Via AccessWire Topics Regulatory Compliance Exposures Legal Regulatory Tickers BTCY Biotricity to Discuss its 2022 Strategic Outlook and Product Pipeline, at Benzinga Healthcare Small Cap Conference on Sept. 30 September 28, 2021 From Biotricity, Inc. Via AccessWire Topics Regulatory Compliance Exposures Legal Regulatory Tickers BTCY Biotricity to Discuss Expansion of Remote Monitoring Medical Device Products at Oppenheimer Fall Healthcare Life Sciences & MedTech Summit on September 22nd September 21, 2021 From Biotricity, Inc. Via AccessWire Topics Regulatory Compliance Exposures Legal Regulatory Tickers BTCY Biotricity Unveils "Biokit" with 3 Personal Medical Devices to Expand into Cardiac Disease Management September 14, 2021 From Biotricity, Inc. Via AccessWire Topics Regulatory Compliance Exposures Legal Product Safety Regulatory Tickers BTCY Biotricity Announces Closing of Exercise of Underwriter's Option to Purchase Additional Common Stock September 13, 2021 From Biotricity, Inc. Via AccessWire Topics Regulatory Compliance Exposures Legal Regulatory Tickers BTCY Biotricity to Discuss Sales Expansion, Recent Financing, and Wearable Medical Device Portfolio Expansion at H.C. Wainwright Conference September 08, 2021 From Biotricity, Inc. Via AccessWire Tickers BTCY Biotricity Completes Nasdaq Listing August 30, 2021 From Biotricity, Inc. Via AccessWire Topics Regulatory Compliance Exposures Legal Regulatory Tickers BTCY Biotricity Prices $15 Million Underwritten Public Offering of Common Stock and Listing on the Nasdaq Capital Market August 26, 2021 From Biotricity, Inc. Via AccessWire Topics Regulatory Compliance Exposures Legal Regulatory Tickers BTCY Biotricity Announces Proposed Underwritten Public Offering of Common Stock in Connection with Expected Nasdaq Listing August 25, 2021 From Biotricity, Inc. Via AccessWire Topics Regulatory Compliance Exposures Legal Regulatory Tickers BTCY Biotricity Reports 290% Revenue Growth Year Over Year in Record First Quarter August 16, 2021 From Biotricity, Inc. Via AccessWire Topics Regulatory Compliance Exposures Legal Product Safety Regulatory Tickers BTCY Biotricity to Report First Quarter Fiscal 2022 Financial Results on August 16, 2021 August 12, 2021 From Biotricity, Inc. Via AccessWire Topics Regulatory Compliance Exposures Legal Regulatory Tickers BTCY Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.